Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amin Rostami

Showing results (71-80 of 305) with videos related to

Pageof 31
Sort By:
The AAPS Journal|February 10, 2015
Choice of LC-MS methods for the absolute quantification of drug-metabolizing enzymes and transporters in human tissue: a comparative cost analysisHajar Al Feteisi, Brahim Achour, Jill Barber, et al.
The AAPS Journal|May 20, 2015
Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug AbsorptionAndrés Olivares-Morales, Hans Lennernäs, Leon Aarons, et al.
Biopharmaceutics & Drug Disposition|April 21, 2023
In-depth analysis of patterns in selection of different physiologically based pharmacokinetic modeling tools: Part I - Applications and rationale behind the use of open source-code softwareArham Jamaal Rajput, Hamza Khaled Abdelmajed Aldibani, Amin Rostami-Hodjegan
Therapeutic Advances in Drug Safety|December 20, 2019
Precision dosing to avoid adverse drug reactionsThomas M Polasek, Carl M J Kirkpatrick, Amin Rostami-Hodjegan
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 5, 2017
Virtual bioequivalence for achlorhydric subjects: The use of PBPK modelling to assess the formulation-dependent effect of achlorhydriaKosuke Doki, Adam S Darwich, Nikunjkumar Patel, et al.
The AAPS Journal|April 5, 2014
Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK modelKhaled Abduljalil, Masoud Jamei, Amin Rostami-Hodjegan, et al.
Drug Discovery Today. Technologies|December 15, 2021
Application of proteomic data in the translation of in vitro observations to associated clinical outcomesSibylle Neuhoff, Matthew D Harwood, Amin Rostami-Hodjegan, et al.
Biopharmaceutics & Drug Disposition|April 21, 2023
In-depth analysis of patterns in selection of different physiologically-based pharmacokinetic modeling tools: Part II - Assessment of model reusability and comparison between open and non-open source-code softwareHamza Khaled Abdelmajed Aldibani, Arham Jamaal Rajput, Amin Rostami-Hodjegan
CPT: Pharmacometrics & Systems Pharmacology|September 29, 2020
Application of the Nested Enzyme-Within-Enterocyte (NEWE) Turnover Model for Predicting the Time Course of Pharmacodynamic EffectsHiroyuki Takita, Adam S Darwich, Amais Ahmad, et al.
The AAPS Journal|September 16, 2016
Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of OxybutyninAndrés Olivares-Morales, Avijit Ghosh, Leon Aarons, et al.
Pageof 31

Showing results (71-80 of 305) with videos related to

Sort By:
Pageof 31
The AAPS Journal|February 10, 2015
Choice of LC-MS methods for the absolute quantification of drug-metabolizing enzymes and transporters in human tissue: a comparative cost analysisHajar Al Feteisi, Brahim Achour, Jill Barber, et al.
The AAPS Journal|May 20, 2015
Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug AbsorptionAndrés Olivares-Morales, Hans Lennernäs, Leon Aarons, et al.
Biopharmaceutics & Drug Disposition|April 21, 2023
In-depth analysis of patterns in selection of different physiologically based pharmacokinetic modeling tools: Part I - Applications and rationale behind the use of open source-code softwareArham Jamaal Rajput, Hamza Khaled Abdelmajed Aldibani, Amin Rostami-Hodjegan
Therapeutic Advances in Drug Safety|December 20, 2019
Precision dosing to avoid adverse drug reactionsThomas M Polasek, Carl M J Kirkpatrick, Amin Rostami-Hodjegan
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 5, 2017
Virtual bioequivalence for achlorhydric subjects: The use of PBPK modelling to assess the formulation-dependent effect of achlorhydriaKosuke Doki, Adam S Darwich, Nikunjkumar Patel, et al.
The AAPS Journal|April 5, 2014
Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK modelKhaled Abduljalil, Masoud Jamei, Amin Rostami-Hodjegan, et al.
Drug Discovery Today. Technologies|December 15, 2021
Application of proteomic data in the translation of in vitro observations to associated clinical outcomesSibylle Neuhoff, Matthew D Harwood, Amin Rostami-Hodjegan, et al.
Biopharmaceutics & Drug Disposition|April 21, 2023
In-depth analysis of patterns in selection of different physiologically-based pharmacokinetic modeling tools: Part II - Assessment of model reusability and comparison between open and non-open source-code softwareHamza Khaled Abdelmajed Aldibani, Arham Jamaal Rajput, Amin Rostami-Hodjegan
CPT: Pharmacometrics & Systems Pharmacology|September 29, 2020
Application of the Nested Enzyme-Within-Enterocyte (NEWE) Turnover Model for Predicting the Time Course of Pharmacodynamic EffectsHiroyuki Takita, Adam S Darwich, Amais Ahmad, et al.
The AAPS Journal|September 16, 2016
Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of OxybutyninAndrés Olivares-Morales, Avijit Ghosh, Leon Aarons, et al.
Pageof 31